SANA Stock Summary and Trading Ideas (Sana Biotechnology | NASDAQ:SANA)

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Sana Biotechnology trades on the NASDAQ stock market under the symbol SANA.

As of June 29, 2026, SANA stock price climbed to $3.45 with 2,356,979 million shares trading.

SANA has a beta of 3.46, meaning it tends to be more sensitive to market movements. SANA has a correlation of 0.20 to the broad based SPY ETF.

SANA has a market cap of $960.11 million. This is considered a Small Cap stock.

In the last 3 years, SANA traded as high as $12.00 and as low as $1.26.

The top ETF exchange traded funds that SANA belongs to (by Net Assets): XBI, VTI, IWM, VXF, IWO.

SANA has underperformed the market in the last year with a return of +20.2%, while the SPY ETF gained +22.3%. In the last 3 month period, SANA fell short of the market, returning +13.9%, while SPY returned +15.2%. However, in the most recent 2 weeks SANA has outperformed the stock market by returning +28.7%, while SPY returned +0.2%.

SANA support price is $3.25 and resistance is $3.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SANA shares will trade within this expected range on the day.